Huaren Pharmaceutical Co., Ltd. (SHE:300110)
3.070
-0.110 (-3.46%)
At close: Mar 20, 2026
Huaren Pharmaceutical Market Cap
Huaren Pharmaceutical has a market cap or net worth of 3.63 billion as of March 20, 2026. Its market cap has decreased by -5.25% in one year.
Market Cap
3.63B
Enterprise Value
4.33B
Revenue
1.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
3.07
Market Cap Chart
Since August 25, 2010, Huaren Pharmaceutical's market cap has increased from 3.48B to 3.63B, an increase of 4.39%. That is a compound annual growth rate of 0.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 3.63B | -2.54% |
| Dec 31, 2025 | 3.72B | -10.51% |
| Dec 31, 2024 | 4.16B | -16.59% |
| Dec 29, 2023 | 4.99B | -0.47% |
| Dec 30, 2022 | 5.01B | -11.67% |
| Dec 31, 2021 | 5.67B | 1.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai MicuRx Pharmaceutical | 4.04B |
| Henan Taloph Pharmaceutical Stock Co.,Ltd | 4.01B |
| Honz Pharmaceutical | 3.84B |
| Shandong Wohua Pharmaceutical | 3.79B |
| Tibet AIM Pharm. | 3.78B |
| Harbin Medisan Pharmaceutical | 3.74B |
| Zhejiang Cheng Yi Pharmaceutical | 3.70B |
| Tuoxin Pharmaceutical Group | 3.60B |